Listen to the article
The FDA has actually revealed an across the country recall of more than 580,000 bottles of high blood pressure medication after tests discovered traces of a cancer-causing chemical in particular batches. The impacted drug, Prazosin Hydrochloride, was dispersed in 1 mg, 2 mg, and 5 mg pill types by Teva Pharmaceuticals and Amerisource Health Solutions.
Health specialists are advising clients not to stop taking their medication quickly, as unchecked high blood pressure can be harmful. Rather, customers need to examine the lot number on their prescription bottles and call their physician or pharmacist if their medication appears on the recall list.
The FDA states the problem includes nitrosamine pollutants, a class of substances connected to an increased threat of cancer with long-lasting direct exposure. Here’s whatever to learn about the high blood pressure medication recall, the drugs impacted, and what actions clients need to take next.
Which High Blood Pressure Medications Were Remembered?
The recall affects Prazosin Hydrochloride pills in 1 mg, 2 mg, and 5 mg strengths, dispersed across the country under the Teva Pharmaceuticals label. More than 580,000 bottles were impacted, with expiration dates varying from April 2026 through September 2027. The drug, typically utilized to deal with hypertension and trauma (PTSD)- associated signs, has actually been pulled from racks due to contamination issues.
Clients can validate if their prescription belongs to the recall by inspecting the lot numbers noted on the FDA’s main recall notification. If a match is discovered, the FDA recommends getting in touch with a doctor before making any medication modifications.
Why Was This High Blood Pressure Medication Remembered?
According to the FDA, the medication included “above appropriate consumption limitations” of a nitrosamine substance called N-nitroso Prazosin pollutant C– part of a class of chemicals connected to an increased threat of cancer. The recall was formally categorized as Class II, indicating the capacity for severe damage is thought about remote however still clinically worrying.
While the FDA’s Class II recall category implies many people are not likely to experience serious impacts, the company cautions that “short-term or clinically reversible negative health repercussions” might happen. Teva kept in mind that alternative treatments for high blood pressure stay commonly offered and declared its dedication to quality assurance, specifying, “There are lots of alternative treatments offered to clients.”
” Teva focuses on client security and item quality at every phase of a medication’s lifecycle.”
The substance, N-nitroso Prazosin pollutant C, can form throughout the production or storage procedure.
Read the full article here
Fact Checker
Verify the accuracy of this article using AI-powered analysis and real-time sources.


